Richard to investigate "Calpain and animal models: towards therapy"
Data presented at the 22nd International World Muscle Society (WMS) Congress -
NEWS PROVIDED BY PTC Therapeutics, Inc
Oct 03, 2017, 10:12 ET
June 13, 2017
Researchers at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) and the University of Nevada, Reno School of Medicine (UNR Med) have demonstrated that a drug originally targeted unsuccessfully to treat cancer may have new life as a potential treatment for Duchenne muscular dystrophy (DMD).